Search research articles
Contact Us
Filters
Showing results (21-30 of 114) with videos related to
Page
of 12
Sort By:
Oncology (Williston Park, N.Y.)
|
October 9, 2004
Trastuzumab in breast cancer
Leisha A Emens, Nancy E Davidson
Cancer Research
|
September 17, 2005
Leveraging the activity of tumor vaccines with cytotoxic chemotherapy
Leisha A Emens, Elizabeth M Jaffee
Med (New York, N.Y.)
|
June 11, 2022
Quiescent cancer cells: Therapeutic targets to overcome immunotherapy resistance?
Leisha A Emens, Ashley Cimino-Mathews
Seminars in Oncology
|
July 19, 2003
The follow-up of breast cancer
Leisha A Emens, Nancy E Davidson
Oncology (Williston Park, N.Y.)
|
October 23, 2003
Toward a breast cancer vaccine: work in progress
Leisha A Emens, Elizabeth M Jaffee
Cancer Biology & Therapy
|
September 26, 2003
Cancer vaccines: an old idea comes of age
Leisha A Emens, Elizabeth M Jaffee
Current Opinion in Molecular Therapeutics
|
October 13, 2007
GV-1001, an injectable telomerase peptide vaccine for the treatment of solid cancers
Pilar Nava-Parada, Leisha A Emens
Expert Opinion on Biological Therapy
|
July 28, 2020
Current and emerging biologic therapies for triple negative breast cancer
Saba S Shaikh, Leisha A Emens
Breast Cancer Research and Treatment
|
October 30, 2021
Emerging combination immunotherapy strategies for breast cancer: dual immune checkpoint modulation, antibody-drug conjugates and bispecific antibodies
Evanthia T Roussos Torres, Leisha A Emens
Methods in Enzymology
|
January 18, 2020
Cytokine profiling of tumor-infiltrating T lymphocytes by flow cytometry
Jeremy B Foote, Sujith Sarvesh, Leisha A Emens
Page
of 12
Search research articles
Search
Showing results (21-30 of 114) with videos related to
Sort By:
Page
of 12
Oncology (Williston Park, N.Y.)
|
October 9, 2004
Trastuzumab in breast cancer
Leisha A Emens, Nancy E Davidson
Cancer Research
|
September 17, 2005
Leveraging the activity of tumor vaccines with cytotoxic chemotherapy
Leisha A Emens, Elizabeth M Jaffee
Med (New York, N.Y.)
|
June 11, 2022
Quiescent cancer cells: Therapeutic targets to overcome immunotherapy resistance?
Leisha A Emens, Ashley Cimino-Mathews
Seminars in Oncology
|
July 19, 2003
The follow-up of breast cancer
Leisha A Emens, Nancy E Davidson
Oncology (Williston Park, N.Y.)
|
October 23, 2003
Toward a breast cancer vaccine: work in progress
Leisha A Emens, Elizabeth M Jaffee
Cancer Biology & Therapy
|
September 26, 2003
Cancer vaccines: an old idea comes of age
Leisha A Emens, Elizabeth M Jaffee
Current Opinion in Molecular Therapeutics
|
October 13, 2007
GV-1001, an injectable telomerase peptide vaccine for the treatment of solid cancers
Pilar Nava-Parada, Leisha A Emens
Expert Opinion on Biological Therapy
|
July 28, 2020
Current and emerging biologic therapies for triple negative breast cancer
Saba S Shaikh, Leisha A Emens
Breast Cancer Research and Treatment
|
October 30, 2021
Emerging combination immunotherapy strategies for breast cancer: dual immune checkpoint modulation, antibody-drug conjugates and bispecific antibodies
Evanthia T Roussos Torres, Leisha A Emens
Methods in Enzymology
|
January 18, 2020
Cytokine profiling of tumor-infiltrating T lymphocytes by flow cytometry
Jeremy B Foote, Sujith Sarvesh, Leisha A Emens
Page
of 12